Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hyperfine, Inc. - Class A Common Stock (NQ: HYPR )

1.020 UNCHANGED
Streaming Delayed Price Updated: 9:39 AM EDT, Oct 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 848
Open 1.000
Bid (Size) 1.010 (1)
Ask (Size) 1.030 (6)
Prev. Close 1.020
Today's Range 1.000 - 1.020
52wk Range 0.7613 - 1.850
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation
From Hyperfine, Inc.
Via Business Wire
Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care
From Hyperfine, Inc.
Via Business Wire

Performance

YTD
-9.73%
-9.73%
1 Month
-2.86%
-2.86%
3 Month
-13.56%
-13.56%
6 Month
+20.00%
+20.00%
1 Year
-39.64%
-39.64%

More News

Read More
Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
From Hyperfine, Inc.
Via Business Wire
HYPR Stock Earnings: Hyperfine Meets EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Hyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Revenue Guidance
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer's Patients
From Hyperfine, Inc.
Via Business Wire
Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images
From Hyperfine, Inc.
Via Business Wire
Portable MRI as a Tissue Clock for Acute Ischemic Stroke: Multi-Site Study to be Published in August 2024 Edition of Annals of Neurology Shows the Value of the Ultra-Low-Field Swoop® Portable MR Imaging® System in Acute Stroke Diagnosis
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024
From Hyperfine, Inc.
Via Business Wire
Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners
From Hyperfine, Inc.
Via Business Wire
Clinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer’s Association International Conference
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to India
From Hyperfine, Inc.
Via Business Wire
The Dollar Menu Portfolio: 7 Penny Stocks to Buy With Spare Change
Via InvestorPlace
Hyperfine, Inc. to Present at the Jefferies Global Healthcare Conference
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Celebrates ASNR 2024
From Hyperfine, Inc.
Via Business Wire
HYPR Stock Earnings: Hyperfine Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Hyperfine, Inc. Reports First Quarter 2024 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
From Hyperfine, Inc.
Via Business Wire
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
From Hyperfine, Inc.
Via Business Wire
HYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.